Clinical trial
An Individualized treatMent aPproach for oldER patIents: A Randomized, Controlled stUdy in Type 2 Diabetes Mellitus (IMPERIUM)
NCT02072096 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Individualized treatMent aPproach for oldER patIents: A Randomized, Controlled stUdy in Type 2 Diabetes Mellitus (IMPERIUM)
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- February 28, 2014
- Completion date
- October 31, 2015
- Enrollment
- 192 (actual)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.